Janux Therapeutics' TRACTr platform shows promise with encouraging early data. Check out what leads me to maintain a “Strong ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

A study indicates that deep belly fat increases the risk of Alzheimer's disease-specific proteins in the brain years before ...

Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most ...

It is said that the intestines are our "second brain," yet many of us still do not appreciate their tremendous role in our ...

Janux Therapeutics' pipeline includes janx007, a tumor-activated T cell engager (TRACT) that targets prostate-specific ...

It is often said that the gut is our "second brain," yet many of us still do not fully appreciate the enormous role that it ...

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) has announced positive updated results from the phase 2b trial of Descartes-08 in participants with generalized myasthenia gravis (MG). The trial showed ...

A fungus discovered in the mouse stomach may hold a key to fungal evolution within the gastrointestinal tract, according to new research led by Weill ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Sudo Biosciences has begun a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory diseases.